Peter Radovich, President and COO of Mirum Pharmaceuticals ($MIRM), made four open market sales of company stock over the last year, totaling $1.14 million. His most recent sale occurred on February 2, 2026. These transactions rank 4,614th among 11,678 insiders by sale value, well below the average of $8.59 million across 6.4 transactions per insider. Radovich made no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 15, 2026 | Mirum Pharmaceuticals, Inc. | $MIRM | Radovich Peter | PRESIDENT AND COO | M | Common Stock | 7220 | $0.00 | 33,787.0000 | 56,993,841 | 27.18% | 0.01% |
| March 15, 2026 | Mirum Pharmaceuticals, Inc. | $MIRM | Radovich Peter | PRESIDENT AND COO | M | Common Stock | 23000 | $0.00 | 56,787.0000 | 56,993,841 | 68.07% | 0.04% |
| March 16, 2026 | Mirum Pharmaceuticals, Inc. | $MIRM | Radovich Peter | PRESIDENT AND COO | S | Common Stock | 16515 | $91.98 | 40,272.0000 | 56,993,841 | 29.08% | 0.03% |
| March 15, 2026 | Mirum Pharmaceuticals, Inc. | $MIRM | Radovich Peter | PRESIDENT AND COO | M | Performance Restricted Stock Units | 7220 | $0.00 | 0.0000 | 56,993,841 | 100.00% | 0.01% |
| March 15, 2026 | Mirum Pharmaceuticals, Inc. | $MIRM | Radovich Peter | PRESIDENT AND COO | M | Performance Restricted Stock Units | 23000 | $0.00 | 11,500.0000 | 56,993,841 | 66.67% | 0.04% |
| March 6, 2026 | Mirum Pharmaceuticals, Inc. | $MIRM | Radovich Peter | PRESIDENT AND COO | M | Stock Option (right to buy) | 5912 | $0.00 | 54,088.0000 | 56,993,841 | 9.85% | 0.01% |
| March 6, 2026 | Mirum Pharmaceuticals, Inc. | $MIRM | Radovich Peter | PRESIDENT AND COO | M | Common Stock | 5912 | $15.87 | 26,567.0000 | 56,993,841 | 28.62% | 0.01% |
| Feb. 2, 2026 | Mirum Pharmaceuticals, Inc. | $MIRM | Radovich Peter | PRESIDENT AND COO | S | Common Stock | 2631 | $103.30 | 20,655.0000 | 56,993,841 | 11.30% | 0.00% |
| Jan. 28, 2026 | Mirum Pharmaceuticals, Inc. | $MIRM | Radovich Peter | PRESIDENT AND COO | A | Performance Restricted Stock Units | 34500 | $0.00 | 34,500.0000 | 56,993,841 | 9999.99% | 0.06% |
| Jan. 28, 2026 | Mirum Pharmaceuticals, Inc. | $MIRM | Radovich Peter | PRESIDENT AND COO | A | Restricted Stock Units | 16280 | $0.00 | 16,280.0000 | 56,993,841 | 9999.99% | 0.03% |
| Jan. 28, 2026 | Mirum Pharmaceuticals, Inc. | $MIRM | Radovich Peter | PRESIDENT AND COO | A | Stock Option (right to buy) | 25120 | $0.00 | 25,120.0000 | 56,993,841 | 9999.99% | 0.04% |
| Jan. 26, 2026 | Mirum Pharmaceuticals, Inc. | $MIRM | Radovich Peter | PRESIDENT AND COO | S | Common Stock | 3143 | $96.19 | 23,286.0000 | 56,993,841 | 11.89% | 0.01% |
| Jan. 23, 2026 | Mirum Pharmaceuticals, Inc. | $MIRM | Radovich Peter | PRESIDENT AND COO | M | Restricted Stock Units | 5750 | $0.00 | 5,750.0000 | 56,993,841 | 50.00% | 0.01% |
| Jan. 23, 2026 | Mirum Pharmaceuticals, Inc. | $MIRM | Radovich Peter | PRESIDENT AND COO | M | Common Stock | 5750 | $0.00 | 26,429.0000 | 56,993,841 | 27.81% | 0.01% |
| Jan. 22, 2026 | Mirum Pharmaceuticals, Inc. | $MIRM | Radovich Peter | PRESIDENT AND COO | S | Common Stock | 2382 | $93.33 | 20,679.0000 | 56,993,841 | 10.33% | 0.00% |
| Jan. 21, 2026 | Mirum Pharmaceuticals, Inc. | $MIRM | Radovich Peter | PRESIDENT AND COO | M | Restricted Stock Units | 4167 | $0.00 | 8,333.0000 | 56,993,841 | 33.34% | 0.01% |
| Jan. 21, 2026 | Mirum Pharmaceuticals, Inc. | $MIRM | Radovich Peter | PRESIDENT AND COO | M | Common Stock | 4167 | $0.00 | 23,061.0000 | 56,993,841 | 22.05% | 0.01% |
| March 15, 2025 | Mirum Pharmaceuticals, Inc. | $MIRM | Radovich Peter | PRESIDENT AND COO | M | Performance Restricted Stock Units | 14440 | $0.00 | 7,220.0000 | 47,522,594 | 66.67% | 0.03% |
| March 15, 2025 | Mirum Pharmaceuticals, Inc. | $MIRM | Radovich Peter | PRESIDENT AND COO | M | Common Stock | 14440 | $0.00 | 26,551.0000 | 47,522,594 | 119.23% | 0.03% |
| March 17, 2025 | Mirum Pharmaceuticals, Inc. | $MIRM | Radovich Peter | PRESIDENT AND COO | S | Common Stock | 7879 | $44.21 | 18,672.0000 | 47,522,594 | 29.67% | 0.02% |
| March 4, 2025 | Mirum Pharmaceuticals, Inc. | $MIRM | Radovich Peter | PRESIDENT AND COO | S | Common Stock | 1169 | $45.74 | 12,111.0000 | 47,522,594 | 8.80% | 0.00% |
| March 4, 2025 | Mirum Pharmaceuticals, Inc. | $MIRM | Radovich Peter | PRESIDENT AND COO | S | Common Stock | 13681 | $45.57 | 13,280.0000 | 47,522,594 | 50.74% | 0.03% |
| Feb. 3, 2025 | Mirum Pharmaceuticals, Inc. | $MIRM | Radovich Peter | PRESIDENT AND COO | S | Common Stock | 2627 | $48.22 | 26,961.0000 | 47,522,594 | 8.88% | 0.01% |
| Jan. 23, 2025 | Mirum Pharmaceuticals, Inc. | $MIRM | Radovich Peter | PRESIDENT AND COO | M | Common Stock | 5750 | $0.00 | 32,765.0000 | 47,522,594 | 21.28% | 0.01% |
| Jan. 23, 2025 | Mirum Pharmaceuticals, Inc. | $MIRM | Radovich Peter | PRESIDENT AND COO | M | Restricted Stock Units | 5750 | $0.00 | 11,500.0000 | 47,522,594 | 33.33% | 0.01% |
| Jan. 24, 2025 | Mirum Pharmaceuticals, Inc. | $MIRM | Radovich Peter | PRESIDENT AND COO | S | Common Stock | 3177 | $47.92 | 29,588.0000 | 47,522,594 | 9.70% | 0.01% |
| Jan. 21, 2025 | Mirum Pharmaceuticals, Inc. | $MIRM | Radovich Peter | PRESIDENT AND COO | A | Restricted Stock Units | 12500 | $0.00 | 12,500.0000 | 47,522,594 | 9999.99% | 0.03% |
| Jan. 21, 2025 | Mirum Pharmaceuticals, Inc. | $MIRM | Radovich Peter | PRESIDENT AND COO | A | Stock Option (right to buy) | 50000 | $0.00 | 50,000.0000 | 47,522,594 | 9999.99% | 0.11% |
| Jan. 21, 2025 | Mirum Pharmaceuticals, Inc. | $MIRM | Radovich Peter | PRESIDENT AND COO | A | Performance Restricted Stock Units | 21660 | $0.00 | 21,660.0000 | 47,522,594 | 9999.99% | 0.05% |
| Jan. 7, 2025 | Mirum Pharmaceuticals, Inc. | $MIRM | Radovich Peter | PRESIDENT AND COO | S | Common Stock | 1998 | $42.82 | 27,015.0000 | 47,522,594 | 6.89% | 0.00% |
| March 25, 2024 | Mirum Pharmaceuticals, Inc. | $MIRM | Radovich Peter | PRESIDENT AND COO | S | Common Stock | 4303 | $25.80 | 29,013.0000 | 40,885,124 | 12.92% | 0.01% |
| Jan. 9, 2023 | Mirum Pharmaceuticals, Inc. | $MIRM | Radovich Peter | PRESIDENT AND COO | S | Common Stock | 1379 | $20.62 | 33,316.0000 | 33,982,493 | 3.97% | 0.00% |
| Feb. 2, 2024 | Mirum Pharmaceuticals, Inc. | $MIRM | Radovich Peter | PRESIDENT AND COO | S | Common Stock | 1790 | $26.19 | 34,695.0000 | 40,885,124 | 4.91% | 0.00% |
| Jan. 23, 2024 | Mirum Pharmaceuticals, Inc. | $MIRM | Radovich Peter | PRESIDENT AND COO | A | Restricted Stock Units | 17250 | $0.00 | 17,250.0000 | 40,885,124 | 9999.99% | 0.04% |
| Jan. 23, 2024 | Mirum Pharmaceuticals, Inc. | $MIRM | Radovich Peter | PRESIDENT AND COO | A | Stock Option (right to buy) | 70000 | $0.00 | 70,000.0000 | 40,885,124 | 9999.99% | 0.17% |
| Jan. 8, 2024 | Mirum Pharmaceuticals, Inc. | $MIRM | Radovich Peter | CHIEF OPERATING OFFICER | S | Common Stock | 1408 | $28.03 | 36,485.0000 | 40,885,124 | 3.72% | 0.00% |